论文部分内容阅读
目的 研究在药物治疗的基础上,配合心理干预治疗对心绞痛型冠心病患者疗效的影响。方法 选2002年9月至2003年9月在本院住院120例患者,均符合1997年10月世界卫生组织/国际心脏病学会制定的冠心病诊断标准。随机分为研究组与对照组各60例。两组性别、年龄无显著性差异。研究组与对照组均接受内科常规药物治疗(降低血小板聚集、硝酸酯类制剂、对症治疗等),研究组患者同时给予BECK认知心理治疗干预及生物反馈治疗。两组分别于入组时及治疗2个月后进行焦虑自评量表(SAS)、抑郁自评量表(SDS)及症状自评量表(SCL—90)评定。两组于治疗前后均进行心电图、血脂、血生化、血液流变学测定。结果 研究组心理干预后SAS、SDS、SCL—90减分率明显高于对照组(P<0.01),临床症状、心电图与对照组差异显著(P<0.01),纤维蛋白原、肾上腺素(E)、去甲肾上腺素(NE)均好转。结论 研究组可以较快控制患者的焦虑、抑郁等负性情绪,调整其心理状态,提高、巩固疗效,改善预后。
Objective To study the effect of psychological intervention on the curative effect of patients with angina pectoris coronary heart disease on the basis of medical treatment. Methods A total of 120 hospitalized patients in our hospital from September 2002 to September 2003 were in accordance with the diagnostic criteria of coronary heart disease developed by the World Health Organization / International Society of Cardiology in October 1997. Randomly divided into study group and control group of 60 cases. Two groups of gender, age no significant difference. Both the study group and the control group received routine medical treatment (reduction of platelet aggregation, nitrates, symptomatic treatment, etc.). Patients in the study group were treated with BECK cognitive psychotherapy and biofeedback therapy. The two groups were assessed by SAS, SDS and SCL-90 after enrollment and two months after treatment. Before and after treatment in both groups were ECG, blood lipid, blood biochemistry, hemorheology. Results The reduction rates of SAS, SDS and SCL-90 in the study group were significantly higher than those in the control group (P <0.01). There were significant differences in clinical symptoms and ECG between the two groups (P <0.01), fibrinogen and adrenaline ), Norepinephrine (NE) were improved. Conclusion The research group can quickly control the patient’s anxiety, depression and other negative emotions, adjust their psychological status, improve and consolidate the efficacy and improve prognosis.